Elite Pharmaceuticals, Inc.
ELTP
$0.40
$0.000.73%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.75% | 22.45% | 92.11% | 36.44% | -13.21% |
| Total Receivables | 18.74% | 12.85% | 24.01% | 58.27% | -13.94% |
| Inventory | 38.17% | -6.16% | 19.19% | -19.43% | 42.31% |
| Prepaid Expenses | 1,381.22% | -74.54% | -43.89% | -14.70% | 777.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.82% | 10.19% | 34.85% | 20.17% | 6.08% |
|
|
|||||
| Total Current Assets | 12.82% | 10.19% | 34.85% | 20.17% | 6.08% |
| Net Property, Plant & Equipment | -2.25% | -2.95% | -2.06% | 1.68% | -2.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.61% | -8.34% | -20.12% | -15.03% | 0.75% |
| Total Assets | 7.82% | 5.31% | 15.51% | 6.20% | 2.90% |
|
|
|||||
| Total Accounts Payable | 90.45% | -32.70% | 72.06% | -49.36% | 194.48% |
| Total Accrued Expenses | -19.35% | 53.70% | 10.82% | 7.52% | -39.18% |
| Short-term Debt | -- | -- | -- | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.89% | 0.62% | 0.71% | -3.44% | -2.96% |
| Total Finance Division Other Current Liabilities | 199.03% | -64.49% | 118.26% | -32.75% | 18.86% |
| Total Other Current Liabilities | 199.03% | -64.49% | 118.26% | -32.75% | 18.86% |
| Total Current Liabilities | 23.55% | -0.83% | -9.10% | -19.39% | 14.28% |
|
|
|||||
| Total Current Liabilities | 23.55% | -0.83% | -9.10% | -19.39% | 14.28% |
| Long-Term Debt | -0.70% | -5.62% | -0.63% | -0.63% | -0.77% |
| Short-term Debt | -- | -- | -- | 0.00% | 0.00% |
| Capital Leases | -10.22% | -8.39% | -8.16% | -6.82% | -5.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -29.70% | -15.89% | 87.74% | -24.92% | 53.72% |
| Total Liabilities | -17.18% | -12.56% | 48.48% | -21.06% | 32.69% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.11% | 0.03% | 0.04% | 0.04% |
| Retained Earnings | 16.47% | 10.82% | -4.88% | 12.34% | -8.59% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 30.41% | 29.16% | -10.90% | 46.83% | -22.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.41% | 29.16% | -10.90% | 46.83% | -22.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.41% | 29.16% | -10.90% | 46.83% | -22.89% |
|
|
|||||